Elite in Metastatic Brain Tumor
Check Dr. Rimas V. Lukas' experience treating your condition:
About Dr. Rimas V. Lukas

Rimas Lukas is a Hematologist Oncology specialist and a Neurologist in Chicago, Illinois. Lukas has been practicing medicine for over 20 years and is rated as an Elite expert by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 34 other conditions, according to our data. His top areas of expertise are Glioblastoma, Glioma, Astrocytoma, and Gliomatosis Cerebri. He is licensed to treat patients in Illinois. Lukas is currently accepting new patients.

His clinical research consists of co-authoring 143 peer reviewed articles and participating in 8 clinical trials in the past 15 years. In particular, he has co-authored 8 articles and participated in 1 clinical trial in the study of Metastatic Brain Tumor.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Rimas V. Lukas it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
259 E Erie St, Chicago, IL 60611
Other Locations
675 N Saint Clair St, Chicago, IL 60611
Background & Education
Graduate Institution
Rush Medical College Of Rush University, 2002
Hematology Oncology
Psychiatry & Neurology in IL
Hospital Affiliations
Northwestern Medicine Lake Forest Hospital
Northwestern Medicine McHenry Hospital
Northwestern Medicine Central DuPage Hospital
Northwestern Memorial Hospital
Shirley Ryan AbilityLab
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Phase 1 / 2 Trial of Blood-brain Barrier Opening With an Implantable Ultrasound Device SonoCloud-9 and Treatment With Albumin-bound Paclitaxel in Patients With Recurrent Glioblastoma
Combination of Checkpoint Inhibition and IDO1 Inhibition Together With Standard Radiotherapy or Chemoradiotherapy in Newly Diagnosed Glioblastoma. A Phase 1 Clinical and Translational Trial
View 2 Less Clinical Trial -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors